Updates on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Part II: Complications, Clinical Trials and New Approaches

On Thursday, July 24, 2008 from 1:30pm – 2:30pm ET, CLL Information Group, Lymphoma Research Foundation and CancerCare brought together a distinguished panel of researchers and clinicians for a lymphoma teleconference entitled Updates on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Part II: Complications, Clinical Trials and New Approaches. 

This program is made possible by an unrestricted educational grant to the Lymphoma Research Foundation from Cephalon Oncology.

To listen to the archived version of this teleconference, click here. 

Program Faculty

Richard R. Furman, MD
Director, CLL Research Center, Weill Cornell Medical College, New York Presbyterian Hospital

Clive S. Zent, MD
Consultant Hematologist, Associate Professor of Medicine, Mayo Clinic

Brian Tomlinson, MPA, BSW
Director, Patient Education, Lymphoma Research Foundation

John Balan
Founder, CLL Information Group

Richard Dickens, MSW
Blood Cancers Program Coordinator, Project Coordinator, Mind/Body Program, CancerCare  

Topics Include

• Complications
• Clinical Trials
• New Treatment Approaches
• Questions for Our Panel of Experts